Related content

Examining the evidence: complementary adjunctive therapies for multiple sclerosis

By Namaka Mike   Crook Arla   Doupe Andrea   Kler Kulwinder   Vasconcelos Marcus   Klowak Meghann   Gong Yuewen   Wojewnik-Smith Alicja   Melanson Maria  

Neurological Research, Vol. 30, Iss. 7, 2008-09 ,pp. : 710-719

Maney Publishing

Access to resources Recommend Favorite

Cell-Based Reparative Therapies for Multiple Sclerosis

By Ben-Hur Tamir   Fainstein Nina   Nishri Yossi  

Current Neurology and Neuroscience Reports, Vol. 13, Iss. 11, 2013-11 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis

By Limmroth Volker   Malessa Rolf   Zettl Uwe   Koehler Jürgen   Japp Gudrun   Haller Peter   Elias Wolfgang   Obhof Winfried   Viehöver Andrea   Meier Uwe   Brosig Arne   Hasford Joerg   Putzki Norman   Kalski Gabriele   Wernsdörfer Colin  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 67-77

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

By Ticha Veronika   Kalincik Tomas   Havrdova Eva  

Neurological Research, Vol. 34, Iss. 10, 2012-12 ,pp. : 923-930

Maney Publishing

Access to resources Recommend Favorite

A Review of “Multiple Sclerosis Therapeutics”

By Ko Michael  

Neuro-Ophthalmology, Vol. 33, Iss. 5, 2009-10 ,pp. : 280-281

Informa Healthcare

Access to resources Recommend Favorite